Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

The development of the new safe and controlled anticoagulant therapy with the use of cationically-modified polymers in the models of experimentally induced arterial and venous thrombosis.

2011/03/B/NZ7/00755

Keywords:

heparin coagulation thrombosis anticoagulants

Descriptors:

  • NZ7_14: Pharmacy, pharmacotherapy, pharmacology

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

woj. podlaskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr hab. Andrzej Mogielnicki 

Number of co-investigators in the project: 11

Call: OPUS 2 - announced on 2011-09-15

Amount awarded: 588 010 PLN

Project start date (Y-m-d): 2012-08-22

Project end date (Y-m-d): 2015-08-21

Project duration:: 36 months (the same as in the proposal)

Project status: Project settled